Subsequent Events (Details) - Subsequent Event [Member] - USD ($) $ / shares in Units, $ in Thousands |
1 Months Ended | 3 Months Ended | |
---|---|---|---|
Jan. 13, 2021 |
Feb. 17, 2021 |
Mar. 31, 2021 |
|
Subsequent Events (Details) [Line Items] | |||
Grant aggregate share | 46,500 | ||
Options to purchase ordinary shares | 46,500 | ||
Exercise price (in Dollars per share) | $ 13.08 | ||
Number of option vest years | 4 years | ||
Sale and issuance of an aggregate shares | 2,000,000 | ||
Purchase price per share (in Dollars per share) | $ 17.50 | ||
Gross proceeds (in Dollars) | $ 35,000 | ||
Investment commissions percentage | 7.00% | ||
Estimated offering expenses (in Dollars) | $ 800 | ||
Subsequent Event, Description | d. On February 24, 2021, CollPlant received a notice of termination from LB, of the License, Development and Commercialization Agreement previously entered into with LB, such termination to be effective March 26, 2021. e During the first quarter of 2021, Alpha exercised 650,000 warrants into 650,000 ADS in return of $2,600. |
X | ||||||||||
- Definition Estimated offering expenses. No definition available.
|
X | ||||||||||
- Definition Grant aggregate share No definition available.
|
X | ||||||||||
- Definition Gross proceeds No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|